Recent Comments

Comment RSS

Dermatitis News and Research RSS Feed - Dermatitis News and Research

Dermatitis is an infection of the skin. The skin may become itchy and progress to a bumpy red rash that may become tender. There may also be pus-filled blisters that are usually found surrounding hair follicles.

Discovery of Th22 cells may help in developing effective therapies for chronic skin and respiratory diseases

20. November 2009 05:41
The newly discovered Th22 cells are a previously unknown subset of T helper cells. T helper cells are white blood cells that help activate other immune cells when the body is infected by viruses or bacteria. At the same time they help the body to tolerate own tissue and to prevent or curb inflammation. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , , , ,

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

17. November 2009 08:04
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany. [More]

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

17. November 2009 07:55
YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, announced that preclinical results for CYT997 were presented today in a poster by Cytopia Limited at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts. [More]

Th22 cell to control inflammation in body to help fight off infection discovered

17. November 2009 06:19
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time this week in the Journal of Clinical Investigation. [More]

Posted in: Medical Science News

Tags: , , , , , ,

Genentech submits sBLAs to the FDA for Avastin

17. November 2009 03:36
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy. [More]

PhotoMedex to host free seminar to fight against psoriasis with XTRAC Excimer Lasers

16. November 2009 07:15
PhotoMedex, Inc. a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. [More]

Occupational contact dermatitis and asthma are most common work-related health issues, says new research

11. November 2009 00:12
Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla. [More]

Posted in: Medical Condition News

Tags: , , , , , , ,

Levulan PDT may reduce the rate of recurrence of SCCs in solid organ transplant recipients: Study

10. November 2009 07:09
The results of an independent investigator study just published in the online version of Dermatologic Surgery demonstrate that Levulan(®) Photodynamic Therapy (PDT) may reduce the rate of recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), a population with a high incidence of nonmelanoma skin cancer. [More]

Stem cell therapy raises hope for autoimmune hearing loss

4. November 2009 07:09
RNL BIO Co., Ltd, a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that it treated an American college student who was suffering from autoimmune hearing loss and she gained her hearing back in two months after treatment. [More]

Safeguard Scientifics reports financial results for the third quarter of 2009

4. November 2009 06:33
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008. [More]

HER2-positive breast cancer patients can be treated with Trastuzumab and adjuvant radiation therapy

4. November 2009 01:49
Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)--typically used in combination with chemotherapy. [More]

Posted in: Women's Health News

Tags: , , , , , ,

Raycop's anti-bacterial vacuum cleaning system with UVC technology kills the H1N1 virus

3. November 2009 06:08
Raycop, the first handheld anti-bacterial vacuum cleaning system and part of the Earlex® brands, offers a proven way to fight the H1N1 virus in the home with its UVC technology. The vac's effects against the virus have been independently tested by a leading international laboratory in August. [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: , , , , , , ,

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

30. October 2009 00:53
TomoTherapy Incorporated announced today that several clinical presentations at the American Society for Radiation Oncology's 51st ASTRO Annual Meeting -- November 1-5, 2009 in Chicago -- will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer. [More]

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

28. October 2009 10:29
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

Seminar on XTRAC Velocity Laser treatments for psoriasis sufferers

28. October 2009 05:45
PhotoMedex, Inc. a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.